IDH1 and brain neoplasm: Based on histomolecular characteristics described in the Materials and methods section, we selected, according to the WHO 2016 classification of brain tumors, 60 IDH-mutant anaplastic astrocytomas (AA) and 44 IDH-mutant GBM that all exhibited loss of ATRX.